Non-Solicitation Policy and Notice to Agencies and Recruiters:

IDEAYAs Non-Solicitation Policy strictly prohibits agencies and recruiters from any contact and communication with IDEAYA employees managers and leaders to submit unsolicited candidate resumes and/or to solicit business partnerships. Submission of unsolicited candidate resumes by agencies or recruiters with or without a contract in place with IDEAYA Biosciences Inc. will not create any implied obligation. Failure to comply with this policy will result in disqualification from current and future business opportunities with IDEAYA Biosciences. All recruiting and talent agency decisions are strictly managed by the internal IDEAYA Human Resources function. All communication by external agencies and recruiters must be directed to We ask that you only email your interest once.

Job Summary

About IDEAYA Biosciences:
IDEAYA is a precision medicine oncology company committed to the discovery development and commercialization of transformative therapies for cancer. Our approach integrates expertise in small-molecule drug discovery structural biology and bioinformatics with robust internal capabilities in identifying and validating translational biomarkers to develop tailored potentially first-in-class targeted therapies aligned to the genetic drivers of disease. We have built a deep pipeline of product candidates focused on synthetic lethality and antibody-drug conjugates or ADCs for molecularly defined solid tumor indications. Our mission is to bring forth the next wave of precision oncology therapies that are more selective more effective and deeply personalized with the goal of altering the course of disease and improving clinical outcomes for patients with cancer.

When youre at IDEAYA you will be in the midst of brilliant minds working on precision medicine therapies to help cancer patients. We are passionate and committed about being on the forefront of oncology medicine which means we all have a high internal drive that is at the very core of every person at IDEAYA. We are inquisitive ask deep questions and are data-driven innovators who like to collaborate and use team work to move science forward. For more information please see .

Location: South San Francisco

Position Summary:
We are seeking a Vice President of Early Oncology Clinical Development to join our IDEAYAs Clinical Development team. The Vice President of Early Oncology Clinical Development is responsible for providing medical direction management and review of clinical trials and product development. Specific tasks include oversight of the strategy and design of clinical development programs for ongoing and new drug candidates clinical protocol development medical monitoring of clinical trials (where needed) and analysis of study data and preparation of trial reports and related regulatory documents. The individual may also serve as Development Project Leader for specific assets as the department evolves and will interact with most functions to ensure the successful progress of projects and clinical trials. This individual will have a solid understanding of all phases of clinical drug development including translational science and operational excellence. Effective written and verbal communication skills are required as is an ability to influence across functions and levels with flexibility/adaptability to work in a fast-paced environment.

This position is based in our South San Francisco headquarters and is required to be onsite four days per week per our company policy.

This position reports to the Senior Vice President Clinical Development.

Job Description

What youll do:

• Oversees all early oncology development program activities and is responsible for execution of programs and timelines
• Applies disease knowledge to clinical research trial development
• Drives protocol development for clinical studies in collaboration with Clinical Operations and other clinical sub-team functions
• Drives preparation of clinical development plans in partnership with cross-functional teams
• Works collaboratively with associated clinical functions to oversee and participate in drafting clinical scientific documents such as IND IND amendments Investigator Brochures Annual Reports (DSUR) and other FDA/HA submissions
• Contributes to CSR preparation and finalization
• In association with clinical operations colleagues and clinical scientists contributes to the development of CRFs and data review plans when needed
• Oversees the Monitoring and review of safety and efficacy data in ongoing studies
• Serves as the key decision maker for clinical questions associated with eligibility AE management etc. for clinical studies
• Participates in developing clinical abstracts and/or presents data at scientific meetings SIVs and conducts protocol training where needed
• Develop and participate in advisory boards
• Keeps abreast of hematology/oncology treatments drug mechanism of action approaches to drug development and regulatory requirements
• Acts as a clinical representative in variety of cross-functional and executive teams
• Partners with Research Translational/Biomarker and other Preclinical teams to help guide advancement of drug candidates with meaningful safety: efficacy profiles
• Serves as clinical partner for Business Development

Requirements:

• Medical degree and medical oncology training required
• Minimum of ten years of clinical drug development experience
• Industry experience required
• Thorough understanding of oncology clinical trial design including first-in-human Phase 1 studies of small molecules
• Experience and understanding of clinical trial data monitoring and all aspects of drug development
• Knowledge of GCP and ICH guidelines
• Leadership and Management experience highly desirable

Personal Strengths:

• A proven self-starter and team player with strong interpersonal skills who establishes & nurtures highly effective relationships with colleagues and key stakeholders to support and advance project goals and objectives
• Critical thinker with a solutions-oriented mindset
• Self-motivated to work effectively in a dynamic environment
• Possess strong organizational skills and conflict resolution abilities
• Deep experience and knowledge in oncology clinical development

Total Rewards

Along with our inspiring mission and highly collaborative and inclusive environment IDEAYA offers a competitive total rewards package that reflects our pay-for-performance philosophy where employees are eligible to be considered for merit-based salary increases company discretionary short-term incentive plan participation and company discretionary stock option awards (based on board approval). Our comprehensive benefits package includes but is not limited to medical/dental/vision coverage (100% company paid for employees and 90% company paid for dependents) 401k ESPP and wellness programs.

The expected salary range for the roleof Vice President Early Oncology Clinical Development is $328000 - $405000. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the office location where this open position is located the final candidates experience within their profession experience in the disease areas we are striving to make an impact in as a company length of time within the industry educational background and performance during the interview process.

The Company complies with all laws respecting equal employment opportunities and does not discriminate against applicants with regard to any protected characteristic as defined by federal state and local law. This position requires you to work onsite in the office at the Companys facilities for training & meetings with work-from-home flexibility and the Company requires that all employees working in its facilities be fully vaccinated (except as required by applicable law). Therefore this position requires you to be fully vaccinated from COVID-19 subject to reasonable accommodations for medical or religious reasons and/or as otherwise required by applicable law. The Company considers you fully vaccinated once 14 days have passed since you received either the second dose in a two-dose COVID-19 vaccine series or a single-dose COVID-19 vaccine. The vaccine must have been FDA approved have emergency use authorization from the FDA or for persons fully vaccinated outside of the U.S. be listed for emergency use by the World Health Organization.

IDEAYA is an equal opportunity accordance with applicable law IDEAYA does not discriminate in hiring or otherwise in employment based on race color religion sex national origin age marital or veteran status disability sexual orientation or any other legally protected status. EOE/AA/Vets.